Story

MarineMax Soars on Buyout Report; Tenax and Sionna Plummet on Failed Drug Trials

ENTHMSVIIDZHZH-TWJAKOHI
Aug 10, 20262 min read
MarineMax Soars on Buyout Report; Tenax and Sionna Plummet on Failed Drug Trials
Text size
Background

Shares of boat retailer MarineMax Inc. surged in premarket trading Monday following a report of a potential buyout, while biotechnology firms Tenax Therapeutics and Sionna Therapeutics saw their stocks plummet after both announced failed clinical trials.

MarineMax Jumps on Acquisition News

MarineMax (HZO) shares jumped more than 34% in premarket activity after Reuters reported that Safe Harbor Marinas, which is owned by Blackstone, is nearing a deal to acquire the company. The potential transaction is valued at approximately $1.5 billion, including debt, according to the report.

The reported offer of $53 per share in cash represents a substantial premium to MarineMax's closing price of $35.68 on Friday. The deal would value the boat retailer's equity at roughly $1.17 billion.

Biotech Trial Failures Trigger Sell-Offs

In the biotechnology sector, two companies experienced massive sell-offs after reporting disappointing clinical data.

Tenax Therapeutics

Sample IUX Markets – In-articleAd

Tenax Therapeutics (TENX) stock plunged 84.2% after the company announced its Phase 3 LEVEL trial for TNX-103, an oral formulation of levosimendan, failed to meet its primary endpoint. The study did not demonstrate a statistically significant improvement in a six-minute walk distance test for patients with a specific type of heart failure, reporting a p-value of 0.63.

Sionna Therapeutics

Sionna Therapeutics (SION) shares collapsed, falling 92.1% after its Phase 2a trial of SION-719 also missed its primary goal. The trial failed to show a meaningful improvement in CFTR function for cystic fibrosis patients, with results that were statistically indistinguishable from a placebo (p-value of 0.7). Sionna stated it will not advance the drug as an add-on to standard treatments based on these results.

Other Notable Premarket Movers

Several other companies saw significant price movement before the opening bell:

  • AAON (AAON): Shares surged more than 10.6% after the heating and cooling equipment manufacturer released second-quarter results that appeared to surpass analyst expectations.
  • Dole (DOLE): The stock fell 4.2% after the fresh produce company reported second-quarter earnings and revenue that missed Wall Street consensus estimates.
  • AirSculpt Technologies (AIRS): Shares dropped 18.4% after the company reported a 3% year-over-year decline in second-quarter revenue and a wider net loss.

Read next

More on Stocks
Back to latest news

LATEST